Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer
1202.7000 1.90 (0.16%)
NSE Aug 08, 2025 11:45 AM
Volume: 623.0K
 

logo
Dr. Reddy's Laboratories Ltd.
06 Nov 2024
1202.70
0.16%
buy
by BOB Capital Markets Ltd.
Target: 1427 | Upside : 18.6%
BOB Capital Markets Ltd.
Revenue/EBITDA earnings above our and street estimates. APAT ~46% above estimates. Estimates adjusted for JV and impairment cost
 
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 29 Jul, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market trades lower, Global Health's Q1FY26 net profit surges 49.6% YoY to Rs 159 crore
Trendlyne Marketwatch | 08 Aug 2025, 11:44AM
Chart of the Week: Mutual funds and FIIs bet big on 11 Nifty 500 stocks in Q1FY26
The Baseline | 07 Aug 2025, 05:53PM
Dr Reddy’s Labs struggles in its biggest market
| 18 Aug 2021